Abstract
Purpose
To study the outcome of therapy for acute endothelial graft rejection with an intravenous (i.v.) pulse of dexamethasone vs methylprednisolone, in addition to topical corticosteroids.
Methods
Records of 98 eyes of 99 patients treated for endothelial graft rejection with a single i.v. pulse of dexamethasone or methylprednisolone in addition to topical steroids, between January 1999 and June 2004, were retrospectively reviewed. Baseline characteristics such as surgery-rejection interval, time taken to consult after onset of symptoms, history of failed grafts, extent of stromal vascularization, best-corrected visual acuity (BCVA) and corneal thickness at the time of presentation were noted. Main outcome measures following treatment for rejection included improvement in BCVA, change in corneal thickness, and reversal of graft rejection.
Results
Fifty-one patients were treated with i.v. methylprednisolone and 47 with i.v. dexamethasone, in addition to topical steroids. Both groups were found to be comparable with respect to baseline parameters, that is, time taken to present, history of failed grafts, extent of stromal vascularization, BCVA, and graft thickness. Graft rejection could be successfully reversed in 72.3% cases in the dexamethasone group and 49% in the methylprednisolone group (P=0.018). A significant improvement in visual acuity was recorded following treatment in both groups, with a better outcome in the dexamethasone group (P=0.012). Post-treatment pachymetry values were lower than pretreatment values in both groups, with significantly lower final pachymetry in the dexamethasone group (P=0.017). No adverse effects were observed.
Conclusion
I.v. pulse therapy with dexamethasone may be used as an effective alternative to methylprednisolone in reversing acute endothelial graft rejection.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Williams KA, Muehlberg SM, Lewis RF, Coster DJ . Long-term outcome in corneal allotransplantation. The Australian Corneal Graft Registry. Transplant Proc 1997; 29: 983.
Vail A, Gore SM, Bradley BA, Easty DL, Rogers CA, Armitage WJ . Conclusions of the cornea transplant follow up study. Br J Ophthalmol 1997; 81: 631–636.
The Collaborative Corneal Transplantation Studies Research Group. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high risk corneal transplantation. Arch Ophthalmol 1992; 110: 1392–1403.
Rinne JR, Stulting RD . Current practices in the prevention and treatment of corneal graft rejection. Cornea 1992; 11: 326–328.
Koay PYP, Lee WH, Figueiredo FC . Opinions on risk factors and management of corneal graft rejection in the United Kingdom. Cornea 2005; 24: 292–296.
Hill JC, Maske R, Watson PG . The use of a single pulse of intravenous methylprednisolone in the treatment of corneal graft rejection. A preliminary report. Eye 1991; 5: 420–424.
Hill JC, Maske R, Watson PG . Corticosteroids in corneal graft rejection: oral versus single pulse therapy. Ophthalmology 1991; 98: 329–333.
Pasricha JA, Khaitan BK, Raman RS, Chandra M . Dexamethasone-cyclophosphamide pulse therapy for pemphigus. Int J Dermatol 1995; 34: 875–882.
Sharada B, Kumar A, Kakker R, Adya CM, Pande I, Uppal SS et al. Intravenous dexamethasone pulse therapy in diffuse systemic sclerosis. A randomized placebo controlled study. Rheumatol Int 1994; 14: 91–94.
Sethi HS, Menon V, Sharma P, Khokhar S, Tandon R . Visual outcome after intravenous dexamethasone therapy for idiopathic optic neuritis in an Indian population: A clinical case series. Ind J Ophthalmol 2006; 54: 177–183.
Ontjes DA . Adrenal corticosteroids. In: Munson PL (ed). Principles of Pharmacology: Basic Concepts and Clinical Application. Chapman and Hall: New York, 1995, pp 749–787.
Khodadaust AA . The allograft rejection reaction: the leading cause of late failure of clinical corneal grafts. In: Porter R, Knight J (eds). Corneal Graft Failure. Elsevier: Amsterdam, 1973, pp 151–164.
Alldredge OC, Krachmer JH . Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment. Arch Ophthalmol 1981; 99: 599–604.
Gibbs DC, Batchelor JR, Werb A, Schlesinger W, Casey TA . The influence of tissue-type compatibility on the fate of full-thickness corneal grafts. Trans Ophthalmol Soc UK 1974; 94: 101–126.
Williams KA, Sawyer MA, White MA, Mahmood MI, Coster DJ . Report from the Australian corneal graft registry. Transplant Proc 1989; 21: 3142–3144.
Hudde T, Minassian DC, Larkin DFP . Randomised controlled trial of corticosteroid regimens in endothelial corneal allograft rejection. Br J Ophthalmol 1999; 83: 1348–1352.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article was presented in part as a poster at the World Cornea Congress, Washington DC, USA in March 2005.
Rights and permissions
About this article
Cite this article
Tandon, R., Verma, K., Chawla, B. et al. Intravenous dexamethasone vs methylprednisolone pulse therapy in the treatment of acute endothelial graft rejection. Eye 23, 635–639 (2009). https://doi.org/10.1038/eye.2008.25
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2008.25
Keywords
This article is cited by
-
Corticosteroids in the management of acute multiple sclerosis exacerbations
Acta Neurologica Belgica (2017)
